These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 21552301

  • 1. Salivary secretion in children after fractionated or single-dose TBI.
    Garming Legert K, Remberger M, Ringdèn O, Heimdahl A, Dahllöf G.
    Bone Marrow Transplant; 2012 Mar; 47(3):404-10. PubMed ID: 21552301
    [Abstract] [Full Text] [Related]

  • 2. Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBI.
    Garming-Legert K, Remberger M, Ringdén O, Hassan M, Dahllöf G.
    Oral Dis; 2011 Oct; 17(7):670-6. PubMed ID: 21718391
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Impact of conditioning regimens on salivary function, caries-associated microorganisms and dental caries in children after bone marrow transplantation. A 4-year longitudinal study.
    Dahllöf G, Bågesund M, Ringdén O.
    Bone Marrow Transplant; 1997 Sep; 20(6):479-83. PubMed ID: 9313881
    [Abstract] [Full Text] [Related]

  • 6. Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation.
    Mattsson J, Uzunel M, Remberger M, Hassan M.
    Bone Marrow Transplant; 2003 Sep; 32(5):477-83. PubMed ID: 12942093
    [Abstract] [Full Text] [Related]

  • 7. Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation.
    Aristei C, Alessandro M, Santucci A, Aversa F, Tabillo A, Carotti A, Latini RA, Cagini C, Latini P.
    Bone Marrow Transplant; 2002 Mar; 29(6):503-7. PubMed ID: 11960270
    [Abstract] [Full Text] [Related]

  • 8. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [Abstract] [Full Text] [Related]

  • 9. Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence.
    Borgmann-Staudt A, Rendtorff R, Reinmuth S, Hohmann C, Keil T, Schuster FR, Holter W, Ehlert K, Keslova P, Lawitschka A, Jarisch A, Strauss G.
    Bone Marrow Transplant; 2012 Feb; 47(2):271-6. PubMed ID: 21478918
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for salivary dysfunction in children 1 year after bone marrow transplantation.
    Dahllöf G, Bågesund M, Remberger M, Ringdén O.
    Oral Oncol; 1997 Sep; 33(5):327-31. PubMed ID: 9415331
    [Abstract] [Full Text] [Related]

  • 11. Neuropsychological outcome in very young hematopoietic SCT recipients in relation to pretransplant conditioning.
    Smedler AC, Winiarski J.
    Bone Marrow Transplant; 2008 Oct; 42(8):515-22. PubMed ID: 18679374
    [Abstract] [Full Text] [Related]

  • 12. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [Abstract] [Full Text] [Related]

  • 13. Longitudinal assessment of hematopoietic stem cell transplantation and hyposalivation.
    Laaksonen M, Ramseier AM, Rovó A, Jensen SB, Raber-Durlacher JE, Zitzmann NU, Waltimo T.
    J Dent Res; 2011 Oct; 90(10):1177-82. PubMed ID: 21734227
    [Abstract] [Full Text] [Related]

  • 14. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
    Abboud I, Porcher R, Robin M, de Latour RP, Glotz D, Socié G, Peraldi MN.
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L, Styczynski J, Komarnicki M.
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [Abstract] [Full Text] [Related]

  • 17. The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation.
    Delgado J, Cooper N, Thomson K, Duarte R, Jarmulowicz M, Cassoni A, Kottaridis P, Peggs K, Mackinnon S.
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):75-83. PubMed ID: 16399571
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of high-dose etoposide administered in combination with fractionated total-body irradiation as conditioning for allogeneic hematopoietic stem cell transplantation in children with acute lymphoblastic leukemia.
    Chrzanowska M, Sobiak J, Grund G, Wachowiak J.
    Pediatr Transplant; 2011 Feb; 15(1):96-102. PubMed ID: 21159109
    [Abstract] [Full Text] [Related]

  • 20. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant.
    Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M, Foppiano F, Sacco O, Cabria M, De Marco R, Stella G, Dallorso S, Bagnasco F, Vitale V, Dini G, Haupt R.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1568-75. PubMed ID: 15990246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.